Skip to main content

Precision Medicine: A New Approach to Cancer Treatment

Thousands of cancer patients are getting medication based on the type of genes driving their disease, not the type of cancer, in a new federal study.

by John Reynolds

Lead image for this article
Credit: Linus Ekenstam

Thousands of cancer patients are getting medication based on the type of genes driving their disease, not the type of cancer, in a new federal study. The approach is a departure from past practice, in which the location of cancer tumors in the patient’s body determined medication. The National Cancer Institute will launch the precision medicine experiment at more than 2,400 locations. (Business Insider)

Information about the authors

John Reynolds’s staff photo

Quality journalism doesn't come free

Perhaps it goes without saying — but producing quality journalism isn't cheap. At a time when newsroom resources and revenue across the country are declining, The Texas Tribune remains committed to sustaining our mission: creating a more engaged and informed Texas with every story we cover, every event we convene and every newsletter we send. As a nonprofit newsroom, we rely on members to help keep our stories free and our events open to the public. Do you value our journalism? Show us with your support.

Yes, I'll donate today